Telix Pharmaceuticals Limited.
TLX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Telix Pharmaceuticals Limited is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic products based on targeted radiopharmaceuticals or molecularly-targeted radiation (MTR). The company's primary focus is on oncology, with a portfolio of clinica...Show More
Better Health for All
0
No evidence available to assess Telix Pharmaceuticals Limited on Better Health for All.
Fair Money & Economic Opportunity
0
Telix Pharmaceuticals Limited is a biopharmaceutical company, not a financial institution.
1
Its core business does not involve lending, insuring, moving, or storing money for consumers. Therefore, the KPIs under the 'Fair Money & Economic Opportunity' value, which are designed for financial services, are not applicable. The company does not offer consumer credit products, have APRs, fee structures for consumer loans, a loan/insurance book, or financial literacy programs for consumers.
2
While Telix has policies and initiatives related to fair pricing of its medical products,
3
data privacy,
4
and expanding access to medicine for underserved populations,
5
these do not align with the specific quantitative thresholds and definitions of the KPIs in this rubric, which are focused on financial services and economic opportunity through financial products.
Fair Pay & Worker Respect
0
No evidence available to assess Telix Pharmaceuticals Limited on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
-40
Telix Pharmaceuticals reported zero substantiated forced- or child-labour findings in both 2023 and 2024.
1
The company has implemented a Supplier Code of Conduct, which key suppliers are required to acknowledge, and utilizes enhanced supplier due diligence, including a digital AI platform, as part of its risk-based approach to managing modern slavery risks.
2
For traceability, partial Tier 2 mapping of radioisotope suppliers was completed in 2024, with further work planned for 2025.
3
The company also incorporates modern slavery clauses into supplier contracts.
4
Honest & Fair Business
-20
Telix Pharmaceuticals has a formal whistleblower protection policy, updated in May 2023, which includes multiple reporting channels, an external independent contact, a 24/7 hotline, and anonymous reporting options.
1
An Anti-Bribery and Anti-Corruption Policy (ABAC) was updated in December 2023, outlining prohibited conduct, exceptions for low-value facilitation payments, record-keeping, and gift/entertainment guidelines with specific thresholds (USD $150 or less vs. over USD $150).
2
Training programs for this policy are in place.
3
The board assesses director independence annually; one Non-Executive Director is not considered independent due to substantial shareholdings and a relationship with ABX-CRO, while all other Non-Executive Directors are considered independent.
4
The company is compliant with the 4th edition of the ASX Corporate Governance Principles and Recommendations in 2024 and is subject to additional corporate governance requirements from SGX, Nasdaq, and SEC.
5
Kind to Animals
-20
Telix Pharmaceuticals has an ethical use of animals policy, which requires all studies involving animals or humans to be developed in association with medical, scientific, and regulatory advisors.
1
These studies reference national and international ethical and scientific codes, including Australia’s National Health and Medical Research Council and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
2
Animal studies are only undertaken when there are no alternatives, represent the only feasible option to advance investigational agents, and only commence after necessary ethics approvals have been received from the institution or clinical site.
3
No War, No Weapons
0
No evidence available to assess Telix Pharmaceuticals Limited on No War, No Weapons.
Planet-Friendly Business
-50
Telix Pharmaceuticals had no known environmental breaches at its operations during the reporting period.
1
The company supports the Task Force on Climate-related Financial Disclosures (TCFD) framework and used it to guide its 2023 climate-related disclosures, with its 2024 reporting framework incorporating guidance from the Australian Sustainability Reporting Standard AASB S2 and the International Sustainability Standards Board's inaugural standards IFRS S1 and IFRS S2.
2
Telix has developed detailed qualitative climate scenario analyses based on two potential future states: a 1.5°C increase in global average temperature by 2040 and a more severe scenario of 2.5°C or higher by 2065.
3
The company formalized its support for the Oncidium Foundation’s RLT-Connect platform in October 2023, which aims to reduce healthcare disparities in low- and middle-income countries.
4
For material usage, 85-95% of zinc-68 is recovered and reprocessed from germanium-68 columns for recycled targets.
5
Respect for Cultures & Communities
0
The provided articles do not contain specific, concrete data points for any of the KPIs related to 'Respect for Cultures & Communities'. While mentions that 'All employees required to attend respect in the workplace training', this is not explicitly defined as 'cultural sensitivity training' nor is a completion percentage provided, making it insufficient for scoring the 'cultural_training_completion' KPI.
1
Therefore, no KPIs can be scored based on the evidence provided.
Safe & Smart Tech
0
Telix Pharmaceuticals holds an ISO 27001:2022 certification, indicating strong information security controls.
1
The company's privacy policy states that users have rights to access, correct, and delete their data, which aligns with industry-standard user controls.
2
Data is retained only as necessary for business operations, particularly under EU GDPR, UK DPA, and Swiss FADP, reflecting standard data minimization practices.
3
Telix mentions compliance with various global privacy laws, including GDPR, CCPA, and HIPAA, as well as adherence to EU Pharmaceutical Legislation and the FIND Act, demonstrating good regulatory compliance.
4
The company's information security controls are aligned with ISO27001:2022, and it conducts ongoing reviews and internal audits of its Information Security Management System (ISMS), which is typical for vulnerability management and security testing coverage.
5
Zero Waste & Sustainable Products
0
Telix Pharmaceuticals' sustainability reports and environmental policy documents indicate a commitment to environmental management, including waste management and compliance with regulations. However, the provided articles lack specific quantitative data for any of the KPIs related to Zero Waste & Sustainable Products. There is no information on waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back program coverage, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability scores, waste audit frequency, zero-waste certifications, waste disposal violations, material efficiency, packaging-to-product ratios, waste reduction targets, supplier waste requirements, or customer waste education.
1
While Article 5 mentions the reuse of a lead shield (100%) and reprocessing of a germanium-68 column (85-95%) for the Illuccix® kit,
2
this information is specific to components of one product and is not presented as a company-wide metric for product recyclability or take-back program coverage.